Medtronic revenue and financials
$87.97Change from previous close: +1.84%Absolute change: +$1.59
In the fiscal year ended April 2026, Medtronic reported revenue of $36.36B (+8.43% year over year). Net income was $4.8B, a net margin of 13.2%.
Fiscal year ending in April. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +8.43%
- FY to Apr 2026 vs FY to Apr 2025
- Net income growth
- +2.98%
- FY to Apr 2026 vs FY to Apr 2025
- Net margin
- 13.2%
- FY to Apr 2025: 13.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Apr 2026 | FY to Apr 2025 | FY to Apr 2024 | FY to Apr 2023 | FY to Apr 2022 | FY to Apr 2021 | FY to Apr 2020 | FY to Apr 2019 | FY to Apr 2018 | FY to Apr 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 36,364 | 33,537 | 32,364 | 31,227 | 31,686 | 30,117 | 28,913 | 30,557 | 29,953 | 29,710 |
| Cost of revenue | 12,721 | 11,632 | 11,216 | 10,719 | 10,145 | 10,483 | 9,424 | 9,155 | 9,067 | 9,294 |
| Gross profit | — | — | — | — | — | — | — | — | 20,898 | 20,419 |
| Operating income | 6,467 | 5,955 | 5,144 | 5,485 | 5,752 | 4,484 | 4,791 | 6,268 | 6,640 | 5,383 |
| Interest expense | — | — | 719 | 636 | 553 | 925 | 1,092 | 1,444 | 1,146 | 1,094 |
| Income tax | 1,299 | 936 | 1,133 | 1,580 | 456 | 265 | -751 | 547 | 2,580 | 578 |
| Net income | 4,801 | 4,662 | 3,676 | 3,758 | 5,039 | 3,606 | 4,789 | 4,631 | 3,104 | 4,028 |
| Basic EPS | 3.75 | 3.63 | 2.77 | 2.83 | 3.75 | 2.68 | 3.57 | 3.44 | 2.29 | 2.92 |
| Diluted EPS | 3.73 | 3.61 | 2.76 | 2.82 | 3.73 | 2.66 | 3.54 | 3.41 | 2.27 | 2.89 |
| Average shares (diluted) | 1,288 | 1,290 | 1,330 | 1,333 | 1,351 | 1,354 | 1,351 | 1,358 | 1,368 | 1,391 |